Pfizer Inc and its German partner BioNTech SE said on Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their Omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years.
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in under-5 kids
By yourbiotechUpdated:No Comments1 Min Read
Previous ArticleSensorion Announces Its Attendance at the 41st Annual J.P. Morgan Healthcare Meeting in San Francisco